Co-Diagnostics appoints CFO Brian L. Brown as Corporate Secretary after Reed Benson resigns

Co-Diagnostics, Inc.

Reed L. Benson resigned as Corporate Secretary effective July 8, 2021; will remain as general counsel and employee.
Brian L. Brown, CPA, already CFO since Feb 2021, appointed as Corporate Secretary.
Resignation not due to any disagreement with management or board.
No compensatory changes or new agreements for Brown's additional role.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brian L. Brown

Corporate Secretary

CODX · Co-Diagnostics, Inc.

Effective: 2021-07-08
Filed: July 9, 2021, 7:59 PM ET

the Company’s Board of Directors appointed Brian L. Brown, CPA, as the Company’s Corporate Secretary.

Role change

Reed L. Benson

Corporate Secretary

CODX · Co-Diagnostics, Inc.

Effective: 2021-07-08
Successor: Brian L. Brown
Filed: July 9, 2021, 7:59 PM ET

Mr. Reed L. Benson resigned as the Corporate Secretary of Co-Diagnostics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Brian L. Brown was appointed as Corporate Secretary at Co-Diagnostics, Inc..

Action: appointed
Role: Corporate Secretary

Exact text from the filing

the Company’s Board of Directors appointed Brian L. Brown, CPA, as the Company’s Corporate Secretary.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Reed L. Benson resigned as Corporate Secretary at Co-Diagnostics, Inc..

Action: resigned
Role: Corporate Secretary

Exact text from the filing

Mr. Reed L. Benson resigned as the Corporate Secretary of Co-Diagnostics, Inc.

View on SEC.gov

Co-Diagnostics, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-21-016480

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.